Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a serious lung disease that causes progressive scarring of the lungs, making it difficult to breathe over time.
Pulmonary Fibrosis: Long-Term Study of BI 1015550
We are investigating the long-term safety and effectiveness of BI 1015550 in patients with pulmonary fibrosis who have previously participated in related studies. This study aims to understand how well the treatment is tolerated and its potential benefits.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Progressive Pulmonary Fibrosis
Progressive pulmonary fibrosis (PPF) refers to a group of lung diseases that cause ongoing scarring of lung tissue, leading to worsening respiratory function.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a woman of childbearing potential and able to use effective birth control methods?
- Do you have any major health issues that could put you at risk in this trial?
- Have you had any suicidal thoughts or behaviors recently?
- Do you have severe depression that affects your daily life?
- Are you currently taking any medications that could interfere with the trial?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bi 1015550
Cyclobutanemethanol
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Krems
Clinical Department for Pneumology
Krems an der Donau, Austria
Krankenhaus Nord Klinik Floridsdorf
Department for Internal Medicine and Pneumology
Langenzersdorf, Austria
Stadt Wien Wiener Gesundheitsverbund
Abteilung für Atemwegs- und Lungenkrankheiten
Perchtoldsdorf, Austria
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.